Aggressive multiple myeloma with lymph node involvement, loss of CD138, and adipophilin-positive cytoplasmic vacuolization: a case report
Authors:
- 22 April 2026
- journal article
- case report
- Published by Springer Nature in Medical Molecular Morphology
- Vol. 59 (3) , 1-6
Abstract
We describe a rare and aggressive case of multiple myeloma (MM) characterized by extensive lymph node involvement, loss of CD138 expression, and adipophilin (ADP)-positive cytoplasmic vacuolization, highlighting the role of lipid metabolism in disease aggressiveness. An 83-year-old woman presented with painless cervical lymphadenopathy and widespread osteolytic lesions. Bone marrow examination confirmed MM, while lymph node biopsy showed diffuse infiltration of atypical lymphoid cells with numerous tingible body macrophages, initially mimicking a high-grade lymphoma. Immunophenotyping showed CD3/CD5/CD20/CD23 negativity, focal CD138/CD79a positivity, diffuse MUM1 and κ-light chain positivity, and a high Ki-67 index. Compared with bone marrow plasma cells, lymph node MM cells exhibited prominent cytoplasmic vacuoles and nuclear enlargement. Immunohistochemistry demonstrated ADP positivity in lymph node lesions but not in bone marrow MM cells, suggesting metabolic reprogramming toward lipid utilization. Despite anti-myeloma therapy, the disease rapidly progressed, and the patient died within two months. This case underscores the clinical significance of CD138 down-regulation as a marker of dedifferentiation and poor prognosis, and suggests that altered lipid metabolism may contribute to the aggressiveness of metastatic MM. To the best of our knowledge, this is the first MM case with lymph node involvement showing CD138 down-regulation and ADP positivity.Keywords
Funding Information
- Grant-in-Aid for Scientific Research (KAKENHI) program (25K02477)
This publication has 9 references indexed in Scilit:
- Prognostic value of fatty acid metabolism-related signature and integrated analysis of the immune microenvironment in multiple myelomaBMC Cancer, 2025
- Cytoplasmic Lipid Droplets Predict Worse Prognosis in Diffuse Large B-Cell LymphomaAmerican Journal of Surgical Pathology, 2024
- Blocking cholesterol efflux mechanism is a potential target for antilymphoma therapyCancer Science, 2022
- Extramedullary disease in multiple myeloma: a systematic literature reviewBlood Cancer Journal, 2022
- Multiple myeloma cells induce lipolysis in adipocytes and uptake fatty acids through fatty acid transporter proteinsBlood, 2022
- Transformation of follicular lymphoma to high-grade Burkitt′s like lymphoma and acute lymphoblastic leukemia-L3 typeIndian Journal of Medical and Paediatric Oncology, 2013
- Multiple myeloma cells expressing low levels of CD138 have an immature phenotype and reduced sensitivity to lenalidomideInternational Journal of Oncology, 2012
- Adipophilin affects the expression of TNF-α, MCP-1, and IL-6 in THP-1 macrophagesMolecular and Cellular Biochemistry, 2009
- Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targetsNature Reviews Cancer, 2007